Median Technologies files FDA 513(g) regulatory submission f

Median Technologies files FDA 513(g) regulatory submission for iBiopsy® Lung Cancer Screening CADe/CADx Software as Medical Device  ·      513(g) submission is a key milestone that marks the initiation of Median’s interactions with the FDA.·  &nbsp...

Related Keywords

France , United States , Shanghai , China , Paris , France General , French , Cade Cadx , Lcs Cade Cadx , Software As Medical Device Sa , Ai Software As Medical Device , Drug Administration , Lcs Cade Cadx Software As Medical Device , Median Technologies , Lung Cancer Screening , United States Food , Medical Device , Fredrik Brag , Artificial Intelligence , Data Science , Euronext Growth , Euronext European Rising Tech ,